Waystar Holding Corp. (WAY)
| Market Cap | 4.80B -21.6% |
| Revenue (ttm) | 1.21B +19.2% |
| Net Income | 134.79M +56.8% |
| EPS | 0.70 +45.5% |
| Shares Out | 191.75M |
| PE Ratio | 35.52 |
| Forward PE | 14.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,542,717 |
| Open | 24.70 |
| Previous Close | 24.84 |
| Day's Range | 24.47 - 25.21 |
| 52-Week Range | 17.26 - 41.47 |
| Beta | 0.06 |
| Analysts | Strong Buy |
| Price Target | 33.17 (+32.63%) |
| Earnings Date | Jul 29, 2026 |
About WAY
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payer payment management, denials prevention and recovery, clinical integrity and revenue capture, and analytics and reporting solutions. It primarily serves healthcare industry. The company was founded in 2017 and is headquartered in Lehi, Utah.
Financial Performance
Financial StatementsAnalyst Summary
According to 24 analysts, the average rating for WAY stock is "Strong Buy." The 12-month stock price target is $33.17, which is an increase of 32.63% from the latest price.
News
Waystar price target lowered to $33 from $38 at Truist
Truist lowered the firm’s price target on Waystar (WAY) to $33 from $38 and keeps a Buy rating on the shares. The firm is updating its model to reflect the…
Waystar price target raised to $27 from $25 at Barclays
Barclays raised the firm’s price target on Waystar (WAY) to $27 from $25 and keeps an Overweight rating on the shares. The firm updated the company’s post the Q2 report.
Waystar price target raised to $39 from $36 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Waystar (WAY) to $39 from $36 and keeps a Buy rating on the shares.
Waystar price target lowered to $32 from $34 at JPMorgan
JPMorgan lowered the firm’s price target on Waystar (WAY) to $32 from $34 and keeps an Overweight rating on the shares.
Waystar price target lowered to $33 from $37 at UBS
UBS lowered the firm’s price target on Waystar (WAY) to $33 from $37 and keeps a Buy rating on the shares.
Waystar price target lowered to $33 from $36 at Wells Fargo
Wells Fargo lowered the firm’s price target on Waystar (WAY) to $33 from $36 and keeps an Overweight rating on the shares. The firm says momentum increasingly centers on executing…
Waystar names Alpana Wegner as CFO
Waystar (WAY) announced the appointment of Alpana Wegner as CFO, effective August 1. Wegner succeeds Steve Oreskovich, who has served as Waystar’s CFO for the past eight years and will…
Waystar Holding Earnings Call Transcript: Q2 2026
Q2 2026 saw 18% revenue growth to $320M and a 43% adjusted EBITDA margin, driven by strong bookings, large client expansion, and robust demand for AI-powered solutions. Guidance for 2026 was raised, with continued investment in AI and automation, and a CFO transition announced.
Waystar Holding Earnings release: Q2 2026
Waystar Holding released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Waystar Holding Quarterly report: Q2 2026
Waystar Holding has published its Q2 2026 quarterly earnings report on July 29, 2026.
Waystar Holding Slides: Q2 2026
Waystar Holding has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Waystar reports Q2 adjusted EPS 43c, consensus 40c
Reports Q2 revenue $319.7M, consensus $316.17M. “Waystar (WAY) delivered another solid quarter, driven by healthy demand, disciplined execution, and growing provider adoption,” said Matt Hawkins, Chie...
Waystar Announces Appointment of Alpana Wegner as Chief Financial Officer
Accomplished technology CFO to help advance Waystar's growth strategy and value creation LEHI, Utah and LOUISVILLE, Ky., July 29, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading heal...
Waystar Reports Second Quarter 2026 Results
Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue and adjusted EBITDA guidance for ...
Waystar price target lowered to $28 from $30 at Citi
Citi analyst Daniel Grosslight lowered the firm’s price target on Waystar (WAY) to $28 from $30 and keeps a Buy rating on the shares. The firm adjusted ratings and targets…
Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market
Report finds that clients using multiple Waystar capabilities achieve the strongest outcomes, highlighting the value of a single, connected platform LEHI, Utah and LOUISVILLE, Ky., July 21, 2026 /PRNe...
Kaskela Law LLC Announces Investigation of Waystar Holding Corp. (WAY) and Encourages Long-Term WAY Shareholders to Contact the Firm
NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating Waystar Holding Corp. (Nasdaq: WAY) (“Waystar”) on behalf of the company's current shareholders. The investigation seeks to determine...
Waystar to Report Second Quarter 2026 Financial Results on July 29, 2026
LEHI, Utah and LOUISVILLE, Ky., July 15, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it will report financial results f...
Waystar initiated with an Overweight at KeyBanc
KeyBanc initiated coverage of Waystar (WAY) with an Overweight rating and $30 price target The firm sees a “large valuation disconnect” at current share levels given the company’s “high-margin growth…
Waystar initiated with an Overweight at KeyBanc
KeyBanc initiated coverage of Waystar (WAY) with an Overweight rating and $30 price target
Waystar to Host Investor Day at Waystar True North™ Conference on August 25, 2026
LEHI, Utah and LOUISVILLE, Ky., July 1, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it will host an Investor Day o...
Waystar price target lowered to $34 from $38 at JPMorgan
JPMorgan lowered the firm’s price target on Waystar (WAY) to $34 from $38 and keeps an Overweight rating on the shares. The firm adjusted targets in the health technology space…
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue
Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., ...
Waystar Holding Transcript: 46th Annual William Blair Growth Stock Conference
AI-driven automation is reducing administrative costs and claim denials in healthcare, with rapid adoption leading to strong revenue and EBITDA growth. The platform's proprietary data and deep integration position it for continued expansion and innovation in a growing market.
Waystar Holding Slides: 46th Annual William Blair Growth Stock Conference
Waystar Holding has posted slides in relation to its latest quarterly earnings report, which was published on June 2, 2026.